Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise (Q68759376)
Jump to navigation
Jump to search
scientific article published on 01 May 1990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise |
scientific article published on 01 May 1990 |
Statements
Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise (English)
P K Lala
J M Scodras
C H Graham
J J Lysiak
1 May 1990